Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletion. | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletion.

Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletion.

Journal Title: 
Blood
Primary Author: 
Steensma DP
Author(s): 
Steensma DP, Ebert BL.
Original Publication Date: 
Thursday, May 23, 2013
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/23704049/

No abstract available.

Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.